Client News
Filter by:
- Dec 16 2022 Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
- Dec 15 2022 Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded
- Dec 15 2022 Genprex Strengthens Diabetes Gene Therapy Program with License of Additional Technology from University of Pittsburgh
- Dec 14 2022 Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial
- Dec 14 2022 Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer
- Dec 13 2022 Investigators Present Clinical Data on Salarius Pharmaceuticals’ Seclidemstat in Patients with MDS and CMML at the 2022 American Society of Hematology Annual Meeting
- Dec 13 2022 Salarius Pharmaceuticals Presents SP-3164 Data Demonstrating Activity in Preclinical Lymphoma Models at the American Society of Hematology Annual Meeting
- Dec 8 2022 Ecolab Appoints Eric Green to Board of Directors
- Dec 8 2022 Ecolab Increases Cash Dividend 4%
- Dec 7 2022 Myomo Provides Update on Progress to Obtain Medicare Part B Reimbursement for MyoPro